Optimization of ebola virus entry inhibitors
Ended Project Grant Awarded Last action
- Award ID
- R43AI138878
- Recipient
-
Arisan Therapeutics Inc. UEI PYRKTQPNVJZ8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $650,000
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $300,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $50,000 | |
| Original award | $300,000 |
Quick answers
Who received award R43AI138878?
R43AI138878 was awarded to Arisan Therapeutics Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 1, 2018.
How much is award R43AI138878 worth?
$650,000 has been obligated on R43AI138878.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award